(Human) FDA prescribing information for the specific GLP-1 medication (for example Ozempic, Wegovy, Mounjaro, or Zepbound)
Systemic exposure of phentermine may increase up to 91%, 45%, and 22% in patients with severe, moderate, and mild renal impairment, respectively [see Dosage and Administration (2.2) and Use in Specific Populations (8.6)]
Keto flu on GLP-1 is worse than keto flu alone Keto flu affects 45 to 60 percent of individuals during the first week of carbohydrate restriction
Downtime after Mounjaro Individual responses may vary, but potential side effects include nausea, emesis, anorexia, and general malaise
All packages, IV Nutrient Packs and first-month Membership promotions are non-transferable and must be used at the studio from which they were purchased